The Thyroid Center at Moffitt is the only one in the Southeast that has the expertise to offer a complete and thorough assessment of thyroid nodules in just one visit, which means faster diagnosis for thyroid patients. The assessment process — from referral to clinical assessment, scans, biopsies and results — typically involves multiple appointments over six weeks.
Evaluating a thyroid nodule for cancer usually involves more than physical examination and blood tests alone. Moffitt’s Thyroid Center assessment streamlines measurement of serum thyrotropin, ultrasound, fine-needle aspiration and integration of molecular studies, with guaranteed same-day results. The impact is significant considering half of the population will have a detectable thyroid nodule by age 60, according to the American Thyroid Association. Moffitt is the only NCI-designated Comprehensive Cancer Center based in Florida to offer research, diagnosis and treatment of thyroid cancer.
Upcoming Moffitt Personalized Medicine Conference, May 16-17, 2014 please visit: http://moffitt.org/PersonalizedMedicine for more information
DR. BRYAN McIVER
Bryan McIver, M.D., Ph.D., is an academic endocrinologist with a strong background in thyroid cancer and thyroid nodules, including both clinical and research interests in these areas. A renowned clinician, respected educator and widely published researcher, Dr. McIver is the program leader in Endocrine Malignancy at Moffitt Cancer Center and professor of Endocrinology at the University of South Florida. Previously, he was a consultant in Endocrinology at Mayo Clinic, Rochester, Minn., and chair of the Mayo Clinic Thyroid Group. Born and raised in Scotland, he received his medical degree from The University of Edinburgh and his Ph.D. in biophysics from the University of Vermont. After residency training at the Royal Infirmary of Edinburgh, he completed a fellowship in Endocrinology at Mayo Clinic and joined the Mayo staff in 1998. Dr. McIver participated in the ATA Guidelines writing committee for the 2006 and 2009 editions and is a charter member of the World Congress on Thyroid Cancer International Organizing Committee.
Moffitt Cancer Center at International Plaza - Thyroid Center
A faster option for assessing patients with thyroid nodules
A coordinated approach for completing assessment in a single visit
From referral to initial consult and scans to results and discussing treatment options, the process for patients with thyroid nodules previously involved several visits, often spread over four to six weeks. The most recent set of guidelines from the American Thyroid Association specifies that the evaluation of a thyroid nodule should include:
- Clinical assessment to determine the number, size and location of all nodules within the gland
- Measurement of serum thyrotropin (TSH) to exclude hyperthyroidism
- Ultrasound to assess the nodule for features of malignancy
- Fine-needle aspiration (FNA) of nodules that meet the appropriate size and ultrasound criteria
- Consideration of use of molecular markers to improve the diagnostic yield for indeterminate cytology
Given the number of steps involved, program leader Bryan McIver, M.D., Ph.D., and the Moffitt Endocrine Tumor Program team have developed a coordinated approach to better serve the needs of these patients and offer the entire assessments process in a single visit. To streamline the evaluation process, Dr. McIver created the Thyroid Center at Moffitt’s outpatient center adjacent to International Plaza – providing NCI-designated cancer care services in treatment, diagnosis and research closer to home.